Researchers continue to excited about the medication , a groundbreaking dual treatment showing promising data in initial trials for size reduction . It acts by targeting two pathways : GLP-1 and GIP, https://emilieokvu890100.mpeblog.com/73518356/this-new-hope-for-size-loss